Jane Street Group, LLC Capricor Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.56 - $15.21 $235,672 - $1.01 Million
66,200 New
66,200 $1.01 Million
Q4 2021

Feb 15, 2022
SELL
$2.89 - $4.16 $37,859 - $54,496
-13,100 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$3.8 - $5.23 $39,140 - $53,869
-10,300 Reduced 44.02%
13,100 $53,000
Q2 2021

Aug 16, 2021
BUY
$3.16 - $5.72 $22,120 - $40,040
7,000 Added 42.68%
23,400 $120,000
Q1 2021

May 18, 2021
BUY
$3.63 - $7.93 $59,532 - $130,052
16,400 New
16,400 $77,000

Others Institutions Holding CAPR

# of Institutions
92
Shares Held
8.13M
Call Options Held
1.78M
Put Options Held
1.4M
View Full List

About CAPRICOR THERAPEUTICS, INC.

CAPR Quotes by TradingView
  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $320M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email